“BREATH COMFORTABLY & SAFELY…WE CARE FOR EVERY BREATH YOU TAKE” ·
“To build a strong entity that contributes to the wellbeing of the society that we serve by facilitating the flow of information among medical practitioner/providers, & by introducing the latest & safest breathing medical solutions & technologies.”.
Area of specialty:
“Anesthesia & Ventilation Division was born on 1 January 2014 for the purpose of serving better breathing management practitioners in the Saudi health care sector by providing the latest technologies in ventilations, anesthesia and veairway management. We do that by partnering with the worldwide market leaders in these fields for more than 50 years, MAQUET CRITICALE CARE & KARL STORZ ANESTHESIA.
Our division vision & motto integrated with Gulf Medical vision, mission & values define our culture, commitments & beliefs.
Our people reflect the same in the way they do things ensuring accurate, reliable & high quality of work. ·
Maquet Is “A Trusted Partner for hospitals and physicians for more than 175 years” and the inventor of electrical ventilation. Since the introduction of the first SERVO ventilator in 1971, SERVO has become the world’s number one ventilation brand. SERVO-i now sets the standard for critical care ventilation. It delivers the highest level of clinical performance to help clinicians provide the best possible care for neonatal, pediatric and adult patients. And now with the introduction on the new Servo family, the Servo-u/n, protective ventilation has become more accessible, understandable and easy to implement. Modeled on the performance and adaptability of previous SERVO generations, SERVO-U is a completely new modular platform that combines the best of the SERVO heritage with significant new advantages in user-friendliness. Servo-u is “The New Power of You”.
FLOW-i “Performance and simplicity when you needed most” is a new generation high performance anesthesia system based on intensive care ventilation for clinics that perform anesthesia across a wide patient spectrum, including those with extra ordinary respiratory demands. FLOW-i is a development deriving from MAQUET’s SERVO platform, adapting to today’s demographic challenges around the world with increasing obesity and an ageing population. Combining advanced ventilator performance and anesthesia delivery in a single patient-friendly unit is an important step forward in anesthesia
FLOW-i is the next great advance in the field of anesthesia.
An instrument is no substitute for a philosophy. In the past 12 years, Karl Storz made significant global contributions to the field of airway management. They have developed scientific solutions for the expected and unexpected difficult airway as well as for training and continued education and have implemented them within algorithms. For standard intubation and difficult airway, video laryngoscope and flexible fiber optics – the battery-operated monitor is accessed in seconds, and all data are safely stored in the form of video clips or images.
“We understand airway management” ·
ANALGESIA MONITORING SOLUTIONS
Rewarding more than 23 years of academic research, conducted in the Lille University Hospital, Mdoloris Medical Systems is an innovative start-up created in June 2010. Our mission is to provide technologies allowing clinicians a reliable, continuous and non-invasive evaluation of patients’ pain and comfort. The objective is to customize the therapeutic to avoid adverse effects of over or under dosing of these drugs. Our technologies make sense when patients are unable to express the pain felt.
Adult and Pediatrics
The ANI technology (Analgesia Nociception Index) is an innovative technology that allows assessing the level of comfort or pain in hospitalized patients. Whether an unconscious patient under general anesthesia or an awake patient in the recovery room, we finally propose an electro-physiological way and objective assessment of the analgesic coverage.
The ANI allows a direct measurement of the activity of the autonomic nervous system (ANS) through the analysis of its parasympathetic component via the respiratory sinus arrhythmia. Our index uses brief and rapid heart rate variations induced by each respiratory cycle (spontaneous or artificial) in order to quantify the parasympathetic tone.
The pain and discomfort evaluation of the newborn is essentially based on hetero-evaluation grids. However, the use of these scales is limited by their subjectivity. This is the reason why the Newborn Infant Parasympathetic Evaluation index (NIPE) has been developed. This index is computed from the electrocardiogram signal recorded by the multi parametric monitor and provides a value that corresponds to the patient’s wellbeing, from birth to two years old.
Based on the results obtained from the ANI technology on the monitoring of non-communicating adults patients, 3 more years of research and development were necessary to give birth to the NIPE index (Newborn Infant Parasympathetic Evaluation). The NIPE technology enables the evaluation of the parasympathetic part of the autonomic nervous system of newborns, from premature to the age of 2 years, from the electrocardiogram provided by the multi parametric monitor.